DIADEMA PARTNERS LP
CIK 0002026172 · MORRISTOWN, NJ · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$791.3M
2026 Q2
Positions
149
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
37.3%
Est. Net Flow (Q)
—
2026 Q2
Portfolio Composition
Sector Allocation
Loading…
Option Positions
PUT 6.7%CALL 16.3%
| Symbol | Company | Type | Notional Value | % Port. |
|---|---|---|---|---|
| VKTX | VIKING THERAPEUTICS INC | CALL | $47.6M | 6.02% |
| ABVX | ABIVAX SA | CALL | $46.5M | 5.88% |
| BMY | BRISTOL-MYERS SQUIBB CO | CALL | $34.6M | 4.37% |
| ABVX | ABIVAX SA | PUT | $33.6M | 4.25% |
| BMY | BRISTOL-MYERS SQUIBB CO | PUT | $19.0M | 2.41% |
13F reports options at notional share-equivalent value; premium cost and strikes are not disclosed.
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.